vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
osteopen 100
chanelle pharmaceuticals manufacturing ltd -
tantum verde 1,5 mg/ml oralno pršilo, raztopina
angelini pharma Ősterreich gmbh - benzidamin - oralno pršilo, raztopina - benzidamin 1,34 mg / 1 ml - benzidamin
tantum verde 1,5 mg/ml raztopina za grgranje in izpiranje ust
angelini pharma Ősterreich gmbh - benzidamin - tekočina za grgranje/izpiranje ust - benzidamin 1,34 mg / 1 ml - benzidamin
tantum verde 1,5 mg/ml raztopina za grgranje in izpiranje ust
angelini pharma Ősterreich gmbh - benzidamin - tekočina za grgranje/izpiranje ust - benzidamin 1,34 mg / 1 ml - benzidamin
tantum verde z okusom evkalipta 3 mg pastile
angelini pharma Ősterreich gmbh - benzidamin - pastila - benzidamin 2,68 mg / 1 pastila - benzidamin
tantum verde z okusom limone 3 mg pastile
angelini pharma Ősterreich gmbh - benzidamin - pastila - benzidamin 2,68 mg / 1 pastila - benzidamin
tantum verde z okusom pomaranče in medu 3 mg pastile
angelini pharma Ősterreich gmbh - benzidamin - pastila - benzidamin 2,68 mg / 1 pastila - benzidamin
tantum verde 3 mg/ml oralno pršilo, raztopina
angelini pharma Ősterreich gmbh - benzidamin - oralno pršilo, raztopina - benzidamin 2,68 mg / 1 ml - benzidamin
tantum verde z okusom pomaranče in medu 3 mg pastile
angelini pharma Ősterreich gmbh - benzidamin - pastila - benzidamin 2,68 mg / 1 pastila - benzidamin